Daniel Tumas
70Patents
16h-index
63Co-inventors
83Inventor score
Filing activity: Aug 19, 1998 → Mar 23, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6635468B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 66 | Expired |
| US7390879B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Chemistry; Metallurgy | 36 | Expired |
| US6410708B1 | Nucleic acids encoding A-33 related antigen polypeptides | Emerging Cross-Sectional Technologies | 36 | Expired |
| US6936436B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Chemistry; Metallurgy | 32 | Expired |
| US7026448B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Chemistry; Metallurgy | 30 | Expired |
| US6569645B2 | IL-17 homologous polypeptides and therapeutic uses thereof | Chemistry; Metallurgy | 30 | Expired |
| US6579520B2 | IL-17 related mammalian cytokine polypeptides (IL-17E) | Chemistry; Metallurgy | 27 | Expired |
| US7192589B2 | Treatment of inflammatory disorders with STIgMA immunoadhesins | Physics | 25 | Expired |
| US7074592B2 | Secreted and transmembrane polypeptides nucleic acid encoding | Chemistry; Metallurgy | 25 | Expired |
| US7419663B2 | Treatment of complement-associated disorders | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6974689B1 | Nucleic acid encoding PRO211 polypeptides | Chemistry; Metallurgy | 24 | Expired |
| US6838554B2 | Nucleic acids encoding proteins that stimulate the proliferation of t-lymphocytes | Emerging Cross-Sectional Technologies | 23 | Expired |
| US7282565B2 | PRO362 polypeptides | Emerging Cross-Sectional Technologies | 22 | Expired |
| US7029874B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Physics | 21 | Expired |
| US7211400B2 | Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens | Emerging Cross-Sectional Technologies | 20 | Expired |
| US8163718B2 | Nucleoside analogues containing phosphonate or phosphonamide groups | Human Necessities | 20 | Active |
| US7442772B2 | Antibodies to PRO361 polypeptide | Chemistry; Metallurgy | 14 | Expired |
| US7282570B2 | Compositions and methods for the treatment of immune related diseases | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7098312B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Chemistry; Metallurgy | 12 | Expired |
| US7189529B2 | PRO792 nucleic acids | Chemistry; Metallurgy | 12 | Expired |
| US7576182B1 | Compositions and methods for the treatment of immune related diseases | Chemistry; Metallurgy | 11 | Expired |
| US7094567B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7026449B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Physics | 10 | Expired |
| US7056736B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7033786B2 | Pro1340 nucleic acids | Chemistry; Metallurgy | 9 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.